Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 1;68(4):425-31.
doi: 10.1097/QAI.0000000000000490.

Impact of hepatitis coinfection on healthcare utilization among persons living with HIV

Trevor A Crowell  1 , Stephen A Berry, John A Fleishman, Richard W LaRue, Philip T Korthuis, Ank E Nijhawan, Richard D Moore, Kelly A Gebo; HIV Research Network
Affiliations

Impact of hepatitis coinfection on healthcare utilization among persons living with HIV

Trevor A Crowell et al. J Acquir Immune Defic Syndr. .

Abstract

: Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection are increasingly important sources of morbidity among HIV-infected persons. We determined associations between hepatitis coinfection and healthcare utilization among HIV-infected adults at 4 US sites during 2006-2011. Outpatient HIV visits did not differ by hepatitis serostatus and decreased over time. Mental health visits were more common among HIV/HCV coinfected persons than among HIV monoinfected persons [incidence rate ratio (IRR): 1.27, 95% confidence interval (CI): 1.08 to 1.50]. Hospitalization rates were higher among all hepatitis-infected groups than among HIV monoinfected (HIV/HBV: IRR: 1.23, 95% CI: 1.05 to 1.44; HIV/HCV: IRR: 1.22, 95% CI: 1.10 to 1.36; HIV/HBV/HCV: IRR: 1.31, 95% CI: 1.02 to 1.68). These findings may inform the design of clinical services and allocation of resources.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author K.A.G. has been a consultant to Tibotec and BMS and received research funding from Tibotec. The other authors report no conflicts of interest.

References

    1. Martin EG, Schackman BR. What does U.S. health reform mean for HIV clinical care? Journal of acquired immune deficiency syndromes. 2012 May 1;60(1):72–76. - PMC - PubMed
    1. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids. 2005 Mar 24;19(6):593–601. - PubMed
    1. Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. Journal of the International AIDS Society. 2011;14:22. - PMC - PubMed
    1. Weber R, Sabin C, Reiss P, et al. HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study. Antiviral therapy. 2010;15(8):1077–1086. - PubMed
    1. Thio CL, Seaberg EC, Skolasky R, Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) Lancet. 2002 Dec 14;360(9349):1921–1926. - PubMed

Publication types